297 related articles for article (PubMed ID: 36329418)
1. Valosin-containing protein Asp395Gly mutation in a patient with frontotemporal dementia: a case report.
Kobayashi R; Naruse H; Kawakatsu S; Iseki C; Suzuki Y; Koyama S; Morioka D; Ishiura H; Mitsui J; Ohta Y; Tsuji S; Toda T; Otani K
BMC Neurol; 2022 Nov; 22(1):406. PubMed ID: 36329418
[TBL] [Abstract][Full Text] [Related]
2. Three VCP Mutations in Patients with Frontotemporal Dementia.
Wong TH; Pottier C; Hondius DC; Meeter LHH; van Rooij JGJ; Melhem S; ; van Minkelen R; van Duijn CM; Rozemuller AJM; Seelaar H; Rademakers R; van Swieten JC
J Alzheimers Dis; 2018; 65(4):1139-1146. PubMed ID: 30103325
[TBL] [Abstract][Full Text] [Related]
3. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.
Cairns NJ; Bigio EH; Mackenzie IR; Neumann M; Lee VM; Hatanpaa KJ; White CL; Schneider JA; Grinberg LT; Halliday G; Duyckaerts C; Lowe JS; Holm IE; Tolnay M; Okamoto K; Yokoo H; Murayama S; Woulfe J; Munoz DG; Dickson DW; Ince PG; Trojanowski JQ; Mann DM;
Acta Neuropathol; 2007 Jul; 114(1):5-22. PubMed ID: 17579875
[TBL] [Abstract][Full Text] [Related]
4. Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brains.
Janssens J; Philtjens S; Kleinberger G; Van Mossevelde S; van der Zee J; Cacace R; Engelborghs S; Sieben A; Banzhaf-Strathmann J; Dillen L; Merlin C; Cuijt I; Robberecht C; Schmid B; Santens P; Ivanoiu A; Vandenbulcke M; Vandenberghe R; Cras P; De Deyn PP; Martin JJ; Maudsley S; Haass C; Cruts M; Van Broeckhoven C;
Acta Neuropathol Commun; 2015 Nov; 3():68. PubMed ID: 26555887
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic variability in three families with valosin-containing protein mutation.
Spina S; Van Laar AD; Murrell JR; Hamilton RL; Kofler JK; Epperson F; Farlow MR; Lopez OL; Quinlan J; DeKosky ST; Ghetti B
Eur J Neurol; 2013 Feb; 20(2):251-8. PubMed ID: 22900631
[TBL] [Abstract][Full Text] [Related]
6. Sex influences clinical phenotype in valosin-containing protein mutations: A case family report and systematic literature review.
Leccese D; Rodolico GR; Sperti M; Cassandrini D; Bartolini M; Ingannato A; Nacmias B; Bracco L; Malandrini A; Santorelli FM; Bessi V; Matà S
Clin Neurol Neurosurg; 2023 Sep; 232():107875. PubMed ID: 37441929
[TBL] [Abstract][Full Text] [Related]
7. One family, one gene and three phenotypes: A novel VCP (valosin-containing protein) mutation associated with myopathy with rimmed vacuoles, amyotrophic lateral sclerosis and frontotemporal dementia.
Abrahao A; Abath Neto O; Kok F; Zanoteli E; Santos B; Pinto WB; Barsottini OG; Oliveira AS; Pedroso JL
J Neurol Sci; 2016 Sep; 368():352-8. PubMed ID: 27538664
[TBL] [Abstract][Full Text] [Related]
8. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.
Seltman RE; Matthews BR
CNS Drugs; 2012 Oct; 26(10):841-70. PubMed ID: 22950490
[TBL] [Abstract][Full Text] [Related]
9. TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations.
Neumann M; Mackenzie IR; Cairns NJ; Boyer PJ; Markesbery WR; Smith CD; Taylor JP; Kretzschmar HA; Kimonis VE; Forman MS
J Neuropathol Exp Neurol; 2007 Feb; 66(2):152-7. PubMed ID: 17279000
[TBL] [Abstract][Full Text] [Related]
10. Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations.
Davis SE; Cook AK; Hall JA; Voskobiynyk Y; Carullo NV; Boyle NR; Hakim AR; Anderson KM; Hobdy KP; Pugh DA; Murchison CF; McMeekin LJ; Simmons M; Margolies KA; Cowell RM; Nana AL; Spina S; Grinberg LT; Miller BL; Seeley WW; Arrant AE
Acta Neuropathol Commun; 2023 Apr; 11(1):70. PubMed ID: 37118844
[TBL] [Abstract][Full Text] [Related]
11. VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death.
Gitcho MA; Strider J; Carter D; Taylor-Reinwald L; Forman MS; Goate AM; Cairns NJ
J Biol Chem; 2009 May; 284(18):12384-98. PubMed ID: 19237541
[TBL] [Abstract][Full Text] [Related]
12. Neuronal VCP loss of function recapitulates FTLD-TDP pathology.
Wani A; Zhu J; Ulrich JD; Eteleeb A; Sauerbeck AD; Reitz SJ; Arhzaouy K; Ikenaga C; Yuede CM; Pittman SK; Wang F; Li S; Benitez BA; Cruchaga C; Kummer TT; Harari O; Chou TF; Schröder R; Clemen CS; Weihl CC
Cell Rep; 2021 Jul; 36(3):109399. PubMed ID: 34289347
[TBL] [Abstract][Full Text] [Related]
13. An autopsy report of a familial amyotrophic lateral sclerosis case carrying VCP Arg487His mutation with a unique TDP-43 proteinopathy.
Matsubara T; Izumi Y; Oda M; Takahashi M; Maruyama H; Miyamoto R; Watanabe C; Tachiyama Y; Morino H; Kawakami H; Saito Y; Murayama S
Neuropathology; 2021 Apr; 41(2):118-126. PubMed ID: 33415820
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of VCP and WASH complex genes in a German cohort of sporadic ALS-FTD patients.
Türk M; Schröder R; Khuller K; Hofmann A; Berwanger C; Ludolph AC; Dekomien G; Müller K; Weishaupt JH; Thiel CT; Clemen CS
Neurobiol Aging; 2017 Aug; 56():213.e1-213.e5. PubMed ID: 28551275
[TBL] [Abstract][Full Text] [Related]
15. Frontotemporal dementia: implications for understanding Alzheimer disease.
Goedert M; Ghetti B; Spillantini MG
Cold Spring Harb Perspect Med; 2012 Feb; 2(2):a006254. PubMed ID: 22355793
[TBL] [Abstract][Full Text] [Related]
16. The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis.
Nalbandian A; Donkervoort S; Dec E; Badadani M; Katheria V; Rana P; Nguyen C; Mukherjee J; Caiozzo V; Martin B; Watts GD; Vesa J; Smith C; Kimonis VE
J Mol Neurosci; 2011 Nov; 45(3):522-31. PubMed ID: 21892620
[TBL] [Abstract][Full Text] [Related]
17. Increased Neurofilament Light Chain and YKL-40 CSF Levels in One Japanese IBMPFD Patient With VCP R155C Mutation: A Clinical Case Report With CSF Biomarker Analyses.
Ikeda M; Kuwabara T; Takai E; Kasahara H; Furuta M; Sekine A; Makioka K; Yamazaki T; Fujita Y; Nagashima K; Higuchi T; Tsushima Y; Ikeda Y
Front Neurol; 2020; 11():757. PubMed ID: 32849216
[TBL] [Abstract][Full Text] [Related]
18. The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene.
Snowden JS; Hu Q; Rollinson S; Halliwell N; Robinson A; Davidson YS; Momeni P; Baborie A; Griffiths TD; Jaros E; Perry RH; Richardson A; Pickering-Brown SM; Neary D; Mann DM
Acta Neuropathol; 2011 Jul; 122(1):99-110. PubMed ID: 21424531
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein L1 is increased in frontotemporal lobar degeneration post-mortem brain but not in ante-mortem cerebrospinal fluid.
Hok-A-Hin YS; Dijkstra AA; Rábano A; Hoozemans JJ; Castillo L; Seelaar H; van Swieten JC; Pijnenburg YAL; Teunissen CE; Del Campo M
Neurobiol Dis; 2022 Oct; 172():105813. PubMed ID: 35820647
[TBL] [Abstract][Full Text] [Related]
20. Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau.
Darwich NF; Phan JM; Kim B; Suh E; Papatriantafyllou JD; Changolkar L; Nguyen AT; O'Rourke CM; He Z; Porta S; Gibbons GS; Luk KC; Papageorgiou SG; Grossman M; Massimo L; Irwin DJ; McMillan CT; Nasrallah IM; Toro C; Aguirre GK; Van Deerlin VM; Lee EB
Science; 2020 Nov; 370(6519):. PubMed ID: 33004675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]